SEC Company Response from Inari Medical, Inc. (NARI) (CIK 0001531048) — May 19, 2020
Inari Medical, Inc. (NARI) (CIK 0001531048)
Date: May 19, 2020 · CIK: 0001531048 · Accession: 0001193125-20-146177
AI Filing Summary & Sentiment
File numbers found in text: 333-236568
Letter
Re: Inari Medical, Inc.
May 19, 2020
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (as amended) (SEC File No. 333-236568)
Ladies and Gentlemen:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Inari Medical, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., New York City time, on May 21, 2020, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we have distributed approximately 690 copies of the Preliminary Prospectus dated May 18, 2020 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and others.
In connection with the Preliminary Prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended.
Very truly yours,
BOFA SECURITIES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 19, 2020 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Inari Medical, Inc. Registration Statement on Form S-1 (as amended) (SEC File No. 333-236568) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Inari Medical, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., New York City time, on May 21, 2020, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, please be advised that we have distributed approximately 690 copies of the Preliminary Prospectus dated May 18, 2020 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and others. In connection with the Preliminary Prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended. Very truly yours, BOFA SECURITIES, INC. MORGAN STANLEY & CO. LLC As Representatives of the several underwriters [SIGNATURE PAGES FOLLOW] BOFA SECURITIES, INC. By: /s/ Michael Liloia Name: Michael Liloia Title: Director MORGAN STANLEY & CO. LLC By: /s/ Chris Rigoli Name: Chris Rigoli Title: Vice President As representatives of the several underwriters. cc: Ilir Mujalovic, Partner, Shearman & Sterling LLP [Signature Page to UW Acceleration Request]